Using an international collection of nearly 900,000 samples, researchers have probed into the biology behind the fairly common loss of an X chromosome in white blood cells.
Phase III clinical trials find that tirzepatide significantly reduced the severity of obstructive sleep apnea and improved related health metrics in adults with moderate-to-severe OSA and obesity.